These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17636185)

  • 1. Evaluation of off-label recombinant activated factor VII for multiple indications in children.
    Reiter PD; Valuck RJ; Taylor RS
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):233-40. PubMed ID: 17636185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric off-label use of recombinant factor VIIa.
    Alten JA; Benner K; Green K; Toole B; Tofil NM; Winkler MK
    Pediatrics; 2009 Mar; 123(3):1066-72. PubMed ID: 19255041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor VII following pediatric cardiac surgery.
    Kylasam S; Mos K; Fijtin S; Webster B; Chard R; Egan J
    J Intensive Care Med; 2009; 24(2):116-21. PubMed ID: 19188273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia.
    Webert KE; Arnold DM; Carruthers J; Molnar L; Almonte T; Decker K; Seroski W; Reed J; Chan AK; Pai M; Walker IR
    Haemophilia; 2007 Sep; 13(5):518-26. PubMed ID: 17880438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
    Blatt J; Gold SH; Wiley JM; Monahan PE; Cooper HC; Harvey D
    Bone Marrow Transplant; 2001 Aug; 28(4):405-7. PubMed ID: 11571515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VII in cardiac surgery: a systematic review.
    Warren O; Mandal K; Hadjianastassiou V; Knowlton L; Panesar S; John K; Darzi A; Athanasiou T
    Ann Thorac Surg; 2007 Feb; 83(2):707-14. PubMed ID: 17258029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register.
    Isbister J; Phillips L; Dunkley S; Jankelowitz G; McNeil J; Cameron P
    Intern Med J; 2008 Mar; 38(3):156-65. PubMed ID: 17916172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.
    Mathew P; Young G
    Haemophilia; 2006 Sep; 12(5):457-72. PubMed ID: 16919075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII in paediatric cardiac surgery.
    Egan JR; Lammi A; Schell DN; Gillis J; Nunn GR
    Intensive Care Med; 2004 Apr; 30(4):682-5. PubMed ID: 14685661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
    Parameswaran R; Shapiro AD; Gill JC; Kessler CM;
    Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic treatment of a small child with severe factor VII deficiency using repeat dosing from a single vial of recombinant activated factor VII.
    Michaels LA; Philipp CS; Eisele J; Pappas H; Saidi P
    Pediatr Blood Cancer; 2007 Oct; 49(5):736-9. PubMed ID: 16317734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
    Grinţescu I; Tulbure D; Mirea L
    Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant factor VIIa for severe intractable bleeding during spine surgery.
    Kaw LL; Coimbra R; Potenza BM; Garfin SR; Hoyt DB
    Spine (Phila Pa 1976); 2004 Jun; 29(12):1384-7; discussion 1388. PubMed ID: 15187645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery.
    Singh SP; Chauhan S; Choudhary M; Vasdev S; Talwar S
    Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):19-23. PubMed ID: 22371937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
    Weiskopf RB
    Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
    Mariani G; Konkle BA; Ingerslev J
    Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.